Janus Henderson Group PLC Acquires New Stake in Clover Health Investments, Corp. (NASDAQ:CLOV)

Janus Henderson Group PLC acquired a new position in shares of Clover Health Investments, Corp. (NASDAQ:CLOV) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 169,300 shares of the company’s stock, valued at approximately $477,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Concurrent Investment Advisors LLC purchased a new stake in shares of Clover Health Investments during the 3rd quarter worth $28,000. Sigma Planning Corp acquired a new position in Clover Health Investments during the third quarter worth about $29,000. Realta Investment Advisors acquired a new position in Clover Health Investments during the third quarter worth about $44,000. Forum Financial Management LP increased its holdings in Clover Health Investments by 33.8% in the third quarter. Forum Financial Management LP now owns 16,077 shares of the company’s stock valued at $45,000 after buying an additional 4,061 shares in the last quarter. Finally, KBC Group NV acquired a new stake in shares of Clover Health Investments during the 3rd quarter valued at approximately $53,000. Hedge funds and other institutional investors own 19.77% of the company’s stock.

Clover Health Investments Stock Up 3.7 %

Clover Health Investments stock opened at $3.11 on Monday. The firm has a market capitalization of $1.56 billion, a PE ratio of -15.55 and a beta of 1.94. The firm’s 50-day simple moving average is $3.65 and its 200 day simple moving average is $2.62. Clover Health Investments, Corp. has a 52 week low of $0.61 and a 52 week high of $4.71.

Clover Health Investments (NASDAQ:CLOV) last released its quarterly earnings results on Wednesday, November 6th. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.03) by $0.01. The company had revenue of $330.99 million during the quarter, compared to the consensus estimate of $347.60 million. Clover Health Investments had a negative return on equity of 25.46% and a negative net margin of 5.92%. During the same quarter last year, the business posted ($0.09) earnings per share. On average, research analysts expect that Clover Health Investments, Corp. will post -0.12 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, UBS Group started coverage on Clover Health Investments in a research note on Monday, October 7th. They issued a “neutral” rating and a $4.00 price objective for the company.

Clover Health Investments Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.